Addus HomeCare (NASDAQ:ADUS) Receives Market Outperform Rating from JMP Securities

JMP Securities restated their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note issued to investors on Thursday,Benzinga reports. JMP Securities currently has a $150.00 price target on the stock.

A number of other equities analysts have also commented on the stock. Oppenheimer raised their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Macquarie reaffirmed an “outperform” rating and set a $129.00 target price on shares of Addus HomeCare in a report on Thursday, February 27th. StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Stephens restated an “overweight” rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. One analyst has rated the stock with a sell rating, one has issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $132.78.

Addus HomeCare Stock Performance

Shares of ADUS opened at $101.77 on Thursday. The firm’s 50-day simple moving average is $101.60 and its 200 day simple moving average is $118.29. The firm has a market cap of $1.85 billion, a P/E ratio of 23.29, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. Addus HomeCare has a 52 week low of $87.88 and a 52 week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, equities analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ADUS. Quarry LP acquired a new position in shares of Addus HomeCare in the third quarter worth approximately $28,000. Natixis increased its stake in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after acquiring an additional 132 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock valued at $35,000 after acquiring an additional 214 shares during the period. Parkside Financial Bank & Trust grew its holdings in Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after purchasing an additional 148 shares during the period. Finally, Meeder Asset Management Inc. bought a new stake in Addus HomeCare in the fourth quarter valued at $77,000. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.